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-Catenin, an intracellular protein, associates with the
COOH-terminal region of cadherin cell adhesion
 
molecules through interactions with either 
 
 
 
-catenin or
 
 
 
-catenin (plakoglobin). The full activity of cadherins re-
quires a linkage to the actin cytoskeleton mediated by
catenins. We transfected 
 
 
 
-catenin–deﬁcient colon carci-
noma cells with a series of 
 
 
 
-catenin constructs to deter-
mine that 
 
 
 
-catenin expression increases the resistance to
apoptosis induced by sphingosine. Two groups of con-
structs, containing deletions in either the middle segment
of the molecule or the COOH terminus, induced morpho-
logical changes, cell compaction, and decreases in cell
death. In 
 
 
 
-catenin–expressing cells, inhibition of cadherin
cell adhesion by treatment with anti–E-cadherin antibodies
 
 
did not decrease the cells viability. 
 
 
 
-Catenin expression
partially suppressed the downregulation of Bcl-xL and the
 
activation of caspase 3. Expression of p27kip1 protein, an
inhibitor of cyclin-dependent kinases, was increased by
 
 
 
-catenin expression in low density cell cultures. The in-
creased levels of p27kip1 correlated with both increased
resistance to cell death and morphological changes in
transfectants containing deletion mutants. Transfection-
mediated upregulation of p27kip1 decreases sphingosine-
 
induced cell death in 
 
 
 
-catenin–deﬁcient cells. We postulate
that 
 
 
 
-catenin mediates transduction of signals from the
 
cadherin–catenin complex to regulate the apoptotic cascade
via p27kip1.
 
Introduction
 
The cadherin family of transmembrane glycoproteins plays
an essential role in the initiation and stabilization of cell–cell
contacts (Takeichi, 1991; Kemler, 1993; Gumbiner, 1996;
Marrs and Nelson, 1996). A conserved cytoplasmic domain,
common to these proteins, interacts with intracellular pro-
teins termed catenins (Ozawa et al., 1989, 1990; Ozawa and
Kemler, 1992; Stappert and Kemler, 1994). The extracellu-
lar domain is responsible for specific homophilic binding
(Nose et al., 1990). Classical cadherins, including E-cadherin,
 
bind to either 
 
 
 
-catenin or 
 
 
 
-catenin (plakoglobin), which
links this complex to 
 
 
 
-catenin. 
 
 
 
-Catenin, a 102-kD pro-
tein, contains multiple interaction sites: actin-binding sites
(Rimm et al., 1995), binding sites for other actin-binding
proteins such as 
 
 
 
-actinin (Nieset et al., 1997), vinculin
(Watabe-Uchida et al., 1998), and ZO-1 (Itoh et al., 1997;
Imamura et al., 1999), and homodimerization sites (Koslov
et al., 1997). Without 
 
 
 
-catenin, cells do not associate
tightly with each other despite the expression of cadherins
(Watabe et al., 1994; Ozawa, 1998; Maeno et al., 1999).
Therefore, the interactions of 
 
 
 
-catenin, linking the cad-
herin–catenin complexes to the actin cytoskeleton, may be
essential to mediate the full activity of cadherins.
Cadherin molecules on the cell surface transduce extracellu-
lar signals (Takeichi, 1991; Larue et al., 1996), possibly alter-
ing cell polarity (McNeill et al., 1990; Watabe et al., 1994),
growth rate (Watabe et al., 1994; Bullions et al., 1997), and
cell–substratum adhesion (Miyaki et al., 1995). However, the
mechanism by which cadherin–catenin complexes regulate
cell fate remains to be investigated.
To examine the functions of 
 
 
 
-catenin, we established
DLD-1/
 
  
 
 cell clones transfected with 
 
 
 
-catenin (Ozawa,
1998). DLD-1/
 
  
 
 is derived from the DLD-1 human colon
cancer cell line, lacking endogenous expression of 
 
 
 
-catenin.
Cadherin-mediated cell adhesion is disrupted in this variant,
despite the presence of other cadherin cell adhesion com-
plex components: E-cadherin, 
 
 
 
-catenin, and 
 
 
 
-catenin. We
searched for the functions of 
 
 
 
-catenin in signal transduc-
tion and found a significant reduction in death of 
 
 
 
-cate-
nin–expressing clones after treatment with sphingosine, an
inducer (Sakakura et al., 1996; Sweeney et al., 1996; Shira-
hama et al., 1997) and endogenous mediator (Ohta et al.,
1994, 1995) of apoptosis. The basic molecular framework
for regulating and executing apoptosis comprises a function-
ally ordered product of expanded gene families, including
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the caspases and Bcl-2 family of proteins. The cadherin/cate-
nin-derived signal may affect the functions and activities of
the molecules in the apoptotic pathways. Therefore, exami-
nation of the effects of cadherin signaling on death media-
tors and/or regulators may uncover the molecular mecha-
nism underlying the signal.
To determine the region of the molecule responsible for
reductions in cell death induction, we examined the cellular
phenotypes, resistance to cell death, and cell morphology,
resulting from deletions in 
 
 
 
-catenin. We compared the ef-
fects of anti–E-cadherin antibody treatment with 
 
 
 
-catenin
deficiency. We then analyzed the status of death mediator
molecules in the apoptosis cascade to find possible mediators
of the signals from cadherin–catenin complexes. Our results
indicate that increases in p27kip1, an inhibitor of cyclin-
dependent kinases (cdks), correlates with resistance to cell
death in the 
 
 
 
-catenin transfectants, suggesting that expres-
sion of 
 
 
 
-catenin effects the cell death through the anti-apop-
totic function of p27kip1. Transfection-mediated upregula-
tion of p27kip1 levels in 
 
 
 
-catenin–deficient cells decreases
the levels of cell death induced by sphingosine, supporting
our hypothesis.
 
Results
 
Reduction of sphingosine-induced cell 
death by 
 
 
 
-catenin expression
 
 
 
D cells, a stable transfectant of a DLD-1/
 
  
 
 variant, ex-
press full-length human 
 
 
 
-catenin; nD cells are a control
vector transfectant (Ozawa, 1998). To induce apoptosis,
cells were plated at 5 
 
  
 
10
 
4
 
 cells per 35-mm dish for 24 h
and then treated with 5–25 
 
 
 
M sphingosine. Cell viability
was then assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-tetrazolium bromide (MTT)* assay. 
 
 
 
D cells
demonstrated significant resistance to sphingosine-induced
cell death compared with nD cells (Fig. 1 A). When cells
were treated with 25 
 
 
 
M sphingosine, a relatively high
concentration, almost all of the cells died within 7 h; there
was no detectable difference between 
 
 
 
D and nD cells.
Upon treatment with lower concentrations of 15–17.5
 
 
 
M, cells died in a time-dependent manner; within 18–24 h,
50–80% of nD cells had been killed. At these critical con-
centrations of sphingosine, 
 
 
 
D cells survived with reduced
levels of cell death. To confirm that observed cell death oc-
curs through apoptosis, we extracted low molecular weight
fragmented DNA from the cells and analyzed the frag-
ments by electrophoresis. Sphingosine induced significant
degradation of DNA into oligo-nucleosomal size fragments
in nD cells (Fig. 1 B), a hallmark of apoptosis. In addition,
direct measurement of nuclear morphology, staining with
DAPI, visualized condensed chromatin and fragmented
nuclei (Fig. 1 C), another characteristic of apoptosis.
Therefore induction of apoptosis after the experimental
treatment with sphingosine was supported by multiple
methods.
 
In high density cultures, cell death is not efficiently in-
duced regardless of 
 
 
 
-catenin expression (unpublished data),
making cell density an important factor in this phenome-
non. When treated with sphingosine in the absence of FCS,
cells died as quickly as cells treated with high concentrations
of sphingosine in the presence of FCS. As a result, no differ-
ences in viability were observed between 
 
 
 
D cells and nD
cells in the absence of FCS (unpublished data).
Therefore, 
 
 
 
-catenin expression in DLD-1/
 
  
 
 cells re-
duced sphingosine-mediated induction of cell death. At the
critical concentrations of the inducer, this effect was ob-
served in low density cultures in the presence of FCS. The
effect was significant and reproducible.
To ascertain the role of 
 
 
 
-catenin in the reduction of
sphingosine-induced cell death, we analyzed pairs of cells
containing or lacking 
 
 
 
-catenin. PC 3, a prostate cancer cell
line, lacks 
 
 
 
-catenin due to homozygous deletion of the gene
(Morton et al., 1993). We transfected PC 3 cells with the
construct used to transfect the DLD-1/
 
  
 
 cells to establish
clones expressing 
 
 
 
-catenin (Fig. 2 A). With these cells, we
got similar results (Fig. 2 B). Upon treatment with sphin-
gosine, we observed a similar reduction of cell death depen-
dent on 
 
 
 
-catenin. The results indicate that the reduction in
levels of sphingosine-induced cell death is a general cellular
phenotype, resulting from the expression of 
 
 
 
-catenin.
 
Identification of the region of 
 
 
 
-catenin that confers 
the increased resistance to cell death
 
To identify the region of 
 
 
 
-catenin necessary to mediate the
anti–cell death effect, we created stable transfectants express-
ing a series of 
 
 
 
-catenin deletion mutants (Fig. 3 A). These
cells expressed 
 
 
 
-catenin polypeptides, containing the NH
 
2
 
-
terminal 
 
 
 
-/
 
 
 
-catenin–binding site and either the middle
or COOH-terminal region. Immunoblot analysis demon-
strated that each transfectant expressed proteins of the ex-
pected size; the levels of expression did not fluctuate signifi-
cantly (Fig. 3 B).
Deletion of amino acids 203–611 in the middle segment
of the protein (
 
  
 
NM1D cells) or of amino acids 614–906
in the COOH-terminal region of 
 
 
 
-catenin (
 
  
 
C1D cells)
did not reduce the viability of transfectants after treatment
with sphingosine (Fig. 3 C). External deletion of the 
 
 
 
-cate-
nin COOH terminus demonstrates that amino acids 1–381
are sufficient to mediate the increase of viability. In contrast,
further deletion of amino acids 203–688 (
 
  
 
NM2) or ex-
ternal deletion of amino acids 303–906 (
 
  
 
C6) reduced the
viability of transfectants compared with cells transfected
with either full-length 
 
 
 
-catenin transfected (
 
 
 
D) or the de-
letion mutants, 
 
  
 
NM1D, 
 
  
 
C1D, and 
 
  
 
C4D. This
data indicated that both the middle and COOH-terminal
regions of 
 
 
 
-catenin are dispensable for this anti–cell death
effect. These regions function similarly, acting redundantly
to reduce cell death. In other words, the combination of the
NH
 
2
 
-terminal 
 
 
 
-/
 
 
 
-catenin–binding site (amino acids 48–
163 in the used fragment of amino acids 1–202; Obama and
Ozawa, 1997) with either amino acids 203–381, in the mid-
dle region of the molecule, or amino acids 612–906, at the
COOH terminus, can induce an increased resistance of
transfectants to sphingosine-induced cell death compared
with 
 
 
 
-catenin–deficient cells.
 
*Abbreviations used in this paper: Ac-DEVD-cmk, acetyl-Asp-Glu-Val-
Asp-chloromethylketone; Ac-DEVD-pNA, acetyl-Asp-Glu-Val-Asp-
 
p
 
-nitro-
anilide; cdk, cyclin-dependent kinase; mAb, monoclonal antibody; MTT,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide. 
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All transfectants exhibiting resistance to cell death demon-
strated compacted aggregation in multicellular suspension
cultures; transfectants sensitive to cell death were loosely ad-
herent, existing as “grape-like” aggregates in multicellular
suspension cultures (Fig. 3 D). Cell compaction (Kemler et
al., 1977; Takeichi, 1977; Hyafil et al., 1980) results from a
cellular morphological change in which cells adhere more
tightly to each other, maximizing contact areas. This effect is
observed in association with cadherin-mediated cell–cell ad-
hesion (Vestweber and Kemler, 1985), involving forces gen-
erated by the actin cytoskeleton (Surani et al., 1990). There-
fore, cells demonstrating the compacted morphotype suggest
a link between the cadherin–catenin complex and the actin
cytoskeleton. These data suggest that transfectants express-
ing 
 
 
 
-catenin variants able to associate with the actin cyto-
skeleton, inducing compaction in three-dimensional cultures,
are resistant to sphingosine-induced cell death.
 
 
 
D, 
 
  
 
C1D, and 
 
  
 
C4D cells demonstrated an epi-
thelioid morphotype when plated on solid substrate;
 
  
 
NM2D, 
 
  
 
C6D, and nD cells showed a nonepithelioid
morphotype with highly refractile cell borders. When plated
on plastic, 
 
  
 
NM1D cells exhibit refractile borders but not
to the same extent as 
 
  
 
NM2D, 
 
  
 
C6D, and nD cells. It
remains unclear why 
 
  
 
NM1D cells do not exhibit an epi-
thelial morphology on solid substrates, although these cells
compact in multicellular suspension cultures. Cell–substra-
tum adhesion may weaken the cell–cell adhesive interactions
of DLD-1 cells.
 
Anti–E-cadherin antibodies induce disruption 
of epithelioid morphotype but do not sensitize
 
 
 
D cells to sphingosine-induced cell death
 
To examine the relationship of this change in morphology
to the 
 
 
 
-catenin–dependent resistance to sphingosine-
induced cell death, we used an anti–human E-cadherin anti-
body, SHE78-7, to disrupt the cell–cell contacts of 
 
 
 
D cells.
The addition of SHE78-7, a function-blocking monoclonal
 
Figure 1.
 
Sphingosine induces apoptosis in DLD-1/
 
  
 
 cells, and 
expression of 
 
 
 
-catenin decreases levels of sphingosine-induced 
cell death
 
. (A) 
 
 
 
-Catenin ( D cells,  ) and control (nD cells,  ) 
transfectants of DLD-1/   cells were treated with the indicated con-
centrations of sphingosine for 18 h. Cell viability was determined by 
the MTT assay, indicated here as a percentage of the absorbance 
observed in the absence of sphingosine. The indicated results are 
the means and SD of triplicate values obtained in one representative 
experiment of five. (B) Sphingosine (Sph)-induced internucleosomal 
DNA fragmentation in nD and  D cells. Cells were treated with 
17.5  M sphingosine for 18 h. The fragmented DNA was then ex-
tracted, analyzed as described in the Materials and methods, and
visualized on a 2% agarose gel. The method does not extract intact 
DNA from normal cells. (C) Sphingosine-induced nuclear conden-
sation and fragmentation. nD cells were treated with 17.5  M 
sphingosine for 9 or 15 h and then stained with DAPI as described 
in the Materials and methods. Floating cell were recovered by cen-
trifuge and also stained. Ut, cells not treated with sphingosine; 9H, 
attached cells treated with sphingosine for 9 h; 15hA, attached cells 
treated for 15 h; 15hF, floating cells treated for 15 h. Essentially the 
same patterns of nuclear morphology were also detected in  D 
cells, both in attached and floating cells after sphingosine treatment, 
although the total number of floating cells were reduced in  D 
cells. Bar, 20  m.576 The Journal of Cell Biology | Volume 154, 2001
antibody (mAb), to cultures disrupts cell–cell contacts to
induce decompaction (Watabe et al., 1994; Kantak and
Kramer, 1998; St. Croix et al., 1998). In the presence of this
antibody,  D cells demonstrated a nonepithelioid morphol-
ogy on solid substrates, similar to that seen with nD cells
(Fig. 4 A). Concentrations from 3 to 100  g/ml induced a
similar morphology without any observable toxicity. Treat-
ment with sphingosine did not reduce the viability of  D
cells in the presence of anti–E-cadherin antibodies (Fig. 4
B). Both the MTT assay and direct counting of cells after
trypsin treatment confirmed that no difference in levels of
cell death was observed between antibody-treated and un-
treated  D cells. SHE78-7 antibodies induce disruption of
homophilic cadherin binding; they are not thought to signal
as a cadherin ligand. Treatment of PC-9 cells, an  -catenin–
deficient cell line, with this antibody overcomes the effect
of  -catenin expression, resulting in cell dissociation and
growth stimulation (Watabe et al., 1994). These results indi-
cate that the inhibition of cell–cell adhesion by function-
blocking antibodies does not have the same effect as the in-
hibition caused by a deficiency of  -catenin, although the
cell morphotype induced by both types of inhibition is quite
similar. Therefore, close cell–cell contacts are not required
for resistance to cell death.
The Bcl-xL protein level in nD cells is lower than that 
in  D cells during induction of cell death by sphingosine
The Bcl-2 family of proteins plays a central role in the regu-
lation of apoptotic cell death. Overexpression of the antiap-
optotic members of this family, Bcl-2 and Bcl-xL, inhibits
apoptosis induced by a wide variety of stimuli (Cory, 1995;
Korsmeyer, 1995; Reed, 1997). Sphingosine-induced apop-
tosis was accompanied by a concomitant decrease on Bcl-2
or Bcl-xL expression as exhibited on both the RNA and pro-
tein levels (Sakakura et al., 1996; Shirahama et al., 1997).
We detected Bcl-xL protein but not Bcl-2 protein in both
 D cells and nD cells by Western blotting (unpublished
data). Sphingosine treatment downregulated the total cellular
levels of Bcl-xL protein; this decrease occurred more quickly
in nD cells than in  D cells. After a 9–12–h treatment with
sphingosine, Bcl-xL levels in  D cells were greater than those
observed in nD cells as observed by Western blot analysis of
equivalent protein amounts (Fig. 5 A). Differences in Bcl-xL
levels were also detected at 3–6 h, before the cells demon-
strated the morphological changes that accompany apoptosis.
After a 15– 24–h treatment with sphingosine, levels of Bcl-xL
and vinculin both decreased in nD cells. Since a large fraction
of nD cells floated and died in this period, these differences in
protein levels could result from cell death. In contrast, no dif-
ferences in the levels of vinculin were detected between  D
and nD cells until 12 h after treatment. These data suggest
that at least one target mediating the increased resistance of
 D cells to cell death may exist upstream of Bcl-xL.
Activation of terminal caspase (caspase 3–like 
proteases) is partially suppressed in  D cells
The caspase family of proteins, highly specialized cysteine pro-
teases, is essential in the regulation and implementation of
apoptosis (Alnemri, 1997; Salvesen and Dixit, 1997; Nunéz et
al., 1998). Initiator caspases are activated by apoptotic stimuli
to activate downstream effector caspases by proteolytic cleav-
age in an amplifying protease cascade. Caspase 3 (CPP 32/
Yama) is a key effector caspase, cleaving substrates after a
DEXD sequence. Z-DEVD-fmk, an inhibitor of caspases 3
and 7, and the wide spectrum caspase inhibitor, Z-VAD-fmk,
Figure 2. Expression of  -catenin decreases sphingosine-induced 
cell death of PC 3 cells. (A) Immunoblot detection of the  -catenin 
polypeptide in PC 3 transfectants. (B)  -Catenin (  PC 3 cells,  ) and 
control (n PC 3 cells,  ) transfectants of PC 3 cells were treated with 
the indicated concentrations of sphingosine for 18 h. Cell viability 
was determined by the MTT assay, indicated here as a percentage of 
absorbance observed in the absence of sphingosine. The indicated 
results are the means and SD of triplicate values obtained in one 
representative experiment of three.
Figure 3. Transfectants expressing mutant  -catenins, inducing compaction in three-dimensional culture, demonstrate reduced sensitivity 
to sphingosine-induced cell death. (A) Schematic representation of  -catenin (top) and mutant  -catenin polypeptides with internal or 
COOH-terminal deletions. The black box designates a HA tag. (B) Immunoblot detection of the  -catenin polypeptide in DLD-1/   cells 
expressing either full-length or mutant  -catenins. Full-length ( D cells) and mutant  -catenin polypeptides possessing deletions in the mid-
dle segment of the molecule (  NM1D and   NM2D cells) were detected with an anti– -catenin mAb; mutant  -catenin polypeptides with 
COOH-terminal deletions (  C1D,   C4D, and   C6D cells) were detected using an anti-HA mAb. (C) Cell viability of stable transfectants 
expressing mutant  -catenins. After treatment for 18 h with 17.5  M sphingosine, cell viability was determined as in the legend to Fig. 1. The 
results are the means and SD of the values obtained in three independent experiments. (D) Aggregates of transfectants expressing mutant  -Catenin–dependent resistance to apoptosis | Matsubara and Ozawa 577
 -catenins in multicellular suspension cultures. Cells were seeded in 35-mm dishes, coated previously with polyhydroxyethylmethacrylate, at 
5   10
4 cells per dish and then incubated for 2 d. (E) Morphology of transfectants expressing mutant  -catenins when plated on a solid sub-
strate. The cell–cell contacts of nD,   NM2D, and   C6D cells but not of  D,   NM1D, and   C4D cells is clear. nD,   NM2D, and 
  C6D cells exhibit highly refractile borders, different from the borders of  D,   NM1D, and   C4D cells. Bars, 50  m.578 The Journal of Cell Biology | Volume 154, 2001
inhibit sphingosine-induced apoptosis (Sweeney et al., 1998),
suggesting that the target of sphingosine exists upstream of
caspase 3 (or caspase 3–like proteases). We used a tetrapeptide
substrate to measure caspase 3 (–like) activity in cells after
treatment with sphingosine. Activity was elevated in both nD
and  D cells after treatment for 9 h with sphingosine; this el-
evation was reduced in  D cells compared with nD cells (Fig.
6). This result indicated that the expression of  -catenin
could inhibit the activation of an effector caspase; the target(s)
of the signal from  -catenin may intervene with the death sig-
nal upstream of caspase 3 (or caspase 3–like proteases).
p27kip1 protein in  D cells is upregulated
in low density cultures
E-cadherin–dependent growth suppression in three-dimen-
sional cultures is mediated by increases in p27kip1, a cdk in-
hibitor (St. Croix et al., 1998). Upregulation of p27kip1 is
also involved in N-cadherin–mediated contact inhibition of
cell growth and entry into S phase (Levenberg et al., 1999).
In addition, p27kip1 provides resistance to cytotoxic drugs
and reduces apoptosis in carcinoma cells grown in confluent
monolayers (Dimanche-Boitrel et al., 1998), multicellular
spheroids (St. Croix et al., 1996), and leukemia cells (Eymin
et al., 1999a). To examine the role of this cdk inhibitor in
resistance to sphingosine-induced cell death, we examined
the levels of p27kip1 in nD and  D cells.
In confluent cultures, p27kip1 protein levels were high; no
differences were detectable between nD and  D cells (Fig.
7). After trypsin/EDTA treatment, p27kip1 protein levels
decreased significantly (unpublished data). After plating 2  
10
5 cells per 100-mm dish, p27kip1 protein levels gradually
increased during a 3-d incubation. In these low density cul-
tures, higher levels of p27kip1 were observed in  D cells in
comparison to nD cells (Fig. 7). Cell death was not effi-
ciently induced in high density cultures, either confluent
cells or cells cultured for more than 3 d after seeding as
Figure 4. Anti–E-cadherin–blocking antibodies disrupt the epithe-
lioid morphology but do not influence sphingosine-induced cell 
death in  D cells. (A) Morphological changes of  D cells after treat-
ment with anti–E-cadherin–blocking antibodies.  D cells were cul-
tured in either 100  g/ml of SHE78-7 antibodies or control mouse 
IgG for 1 d. (B) nD and  D cells were cultured in either 100  g/ml 
of SHE78-7 antibodies or control mouse IgG for 1 d, then treated 
with 17.5  M sphingosine for 18 h in the continuing presence of 
the antibody. Cell viability was determined by the MTT assay. The 
results are shown as the means and SD of the values obtained in 
four independent experiments. Bar, 50  m.
Figure 5. Bcl-xL protein levels in nD and  D cells during sphin-
gosine induction of cell death. (A) Cells were treated with 17.5  M 
sphingosine for the indicated times. 15  g of protein per lane obtained 
from whole cell extracts was subjected to Western blot analysis us-
ing antibodies against Bcl-xL and vinculin. Antivinculin antibodies 
were used to identify fluctuations in the protein amount between 
nD and  D cells. J indicates Jurkat cells, used as a positive control 
for Bcl-xL protein. The experiment was repeated four times with 
similar results obtained each time. (B) The relative intensity of 
Bcl-xL bands in A was determined by densitometry. These values 
are indicated as the ratio to the intensity of Jurkat cells (  1.0).  , 
nD cells;  ,  D cells. -Catenin–dependent resistance to apoptosis | Matsubara and Ozawa 579
above, regardless of  -catenin expression (unpublished data).
These results suggest a correlation between p27kip1 expres-
sion and resistance to cell death. DLD-1/   transfectants
expressing a level of p27kip1 above a certain threshold, such
as that seen in high density cultures, cannot be induced to
undergo cell death by sphingosine treatment. Cells express-
ing lower levels of p27kip1, such as cells present in low den-
sity cultures, undergo cell death after sphingosine treatment.
In this case, the upregulation of p27kip1 resulting from  -cat-
enin expression correlates with reductions in cell death.
The correlation between increased levels of p27kip1 and in-
creased resistance to cell death in low density cultures was also
observed for transfectants expressing  -catenin deletion
mutants. The  -catenin mutant transfectants,   NM1D,
  C1D, and   C4D cells, demonstrated an upregulation in
the levels of p27kip1 similar to those of  D cells in low density
cultures. In contrast, the expression of p27kip1 in   NM2D
and   C6D cells was reduced, similar to levels seen in nD cells
(Fig. 8). p21cip1, another member of the CIP/KIP family of
kinase inhibitors, was not detectable by Western blot analysis
in either nD or  D cells (unpublished data).
Increased expression of p27kip1 reduces
sphingosine-induced cell death of  -catenin–deficient 
(DLD-1/  ) cells
To assess the role of p27kip1 in resistance to sphingosine-
induced cell death, we overexpressed p27kip1 in  -catenin–
deficient (DLD-1/  ) cells. Cells were stably transfected with
a vector containing the full-length human p27kip1 cDNA
with an HA tag. We selected clones by Western blot analysis
using anti-p27kip1 antibodies (Fig. 9 A). Quantitative immu-
noblotting, after making serial dilutions of extracts, revealed
that representative clones (p27HAD cells) contained a total
amount of p27kip1 protein (tagged and endogenous protein)
approximately two to three times that of control transfectants
in low density cultures, the conditions used in sphingosine
treatment (unpublished data). This is a similar amount to  D
cells in the same conditions (Figs. 7 and 8).
Elevated expression of p27kip1 in DLD-1/   cells re-
duced the level of cell death induced by sphingosine (Fig. 9
B). This resistance to cell death was observed with the criti-
cal inducer concentrations observed for nD and  D cells.
These results suggest that increased p27kip1 levels mediate
the increased survival of  -catenin–expressing cells.
 -Catenin expression does not suppress 
the growth of DLD-1/   cells
p27kip1 inhibits cyclin E-CDK 2 activity implicated in the
negative regulation of G1 progression. Therefore, we exam-
Figure 6. The activation of caspase 3 (–like proteases) is partially 
suppressed in  D cells. After treatment with 17.5  M sphingosine 
(Sph) for 9 h, cell extracts were used to determine the caspase 3 
(–like) activity with Ac-DEVD-pNA as a substrate. Relative activities 
are indicated as a fold increase as compared with the activity of 
untreated nD cells (  1.0). The results are shown as the means and 
SD of the values obtained in three independent experiments.
Figure 7. Levels of p27kip1 are upregulated in low density cul-
tures of  D cells. (A) Cells were grown to confluency and then 
treated with trypsin/EDTA. Single cell suspensions were seeded at 
2   10
5 cells per 100-mm dish, then incubated for the indicated 
times. 20  g of protein per lane, obtained from whole cell extracts, 
was subjected to Western blot analysis using antibodies against 
p27kip1 and vinculin. Antivinculin antibodies were used to identify 
fluctuations in total protein amounts. A longer exposure of the blot 
(Day 1) is shown at the bottom. (B) The relative intensity of p27kip1 
was measured by densitometry and calculated from three indepen-
dent experiments. Values are shown as the ratio to the intensity of 
 D cells on day 2 (  1.0).  , nD cells;  ,  D cells. The p27kip1 
protein levels in confluent nD and  D cells are represented as 
hatched and black bars, respectively.580 The Journal of Cell Biology | Volume 154, 2001
ined the effect of p27kip1 upregulation in low density cul-
tures of  D cells on cell growth.  -Catenin expression did
not affect the growth of DLD-1/   cells (Fig. 10), in con-
trast to previous results with PC 9 cells (Watabe et al., 1994)
and Ov2008 cells (Bullions et al., 1997). The growth of
these two  -catenin–deficient cell lines is retarded after the
restoration of  -catenin expression.
Discussion
The exogenous expression of  -catenin in  -catenin–deficient
cells restores and/or enhances cell adhesion to result in a com-
pacted and/or an epithelioid morphotype (Watabe et al.,
1994; Ewing et al., 1995; Bullions et al., 1997; Ozawa, 1998;
Watabe-Uchida et al., 1998; Maeno et al., 1999). The resto-
ration of cadherin-dependent cell adhesion was occasionally
accompanied by the retardation of cell growth (Watabe et al.,
1994; Bullions et al., 1997), a reduced ability to form colonies
in vitro (Ewing et al., 1995; Bullions et al., 1997), the sup-
pression of tumorigenesis in vivo (Ewing et al., 1995; Bullions
et al., 1997), and the assembly of apical junctional complexes,
including tight junctions (Watabe et al., 1994; Watabe-
Uchida et al., 1998). The restoration of  -catenin expression
in DLD-1/   cells, an  -catenin–deficient colon carcinoma
cell line, resulted in an epithelioid morphotype but did not
induce growth suppression. After the induction of cell death
by exogenous stimuli, such as sphingosine, the expression of
 -catenin reduced cell death within a critical concentration
range of the inducer. This reduction of cell death resulting
from  -catenin expression was also observed in PC 3 cells, an
additional  -catenin–deficient cell line derived from a human
prostate cancer. This is the first report of a reduction of cell
death induced by the expression of  -catenin.
Figure 8. Mutant  -catenin transfectants exhibiting close cell–cell 
contacts demonstrate increased levels of p27kip1 in low density 
cultures. (A) Cells were seeded at 2   10
5 cells per 100-mm dish 
and incubated for 2 d. 25  g of protein per lane, obtained from 
whole cell extracts, was subjected to Western blot analysis using 
antibodies against p27kip1 and vinculin. Antivinculin antibodies 
identified fluctuations in total protein levels. (B) The relative inten-
sity of p27kip1 bands was measured by densitometry. Values were 
calculated from two independent experiments as the ratio to the 
intensity of  D cells on day 2 (  1.0).
Figure 9. Transfection-mediated upregulation of p27kip1 levels in 
 -catenin–deficient cells decreases levels of sphingosine-induced 
cell death. (A) Immunoblot detection of p27kip1 protein in p27HA 
and control transfectants of DLD-1/   cells. 25  g of protein per 
lane, obtained from whole cell extracts, was subjected to Western 
blot analysis using antibodies against p27kip1. (B) DLD-1/   cells 
expressing exogenous p27 (p27HAD cells,  ) and control transfec-
tants (neoD cells,  ) were treated for 18 h with the indicated con-
centrations of sphingosine. Cell viability was determined by the MTT 
assay, indicated as a percentage of absorbance observed in the ab-
sence of sphingosine. The indicated results are the means and SD of 
triplicate values obtained in one representative experiment of four. -Catenin–dependent resistance to apoptosis | Matsubara and Ozawa 581
In the present study, we could not directly measure the
rate of entry into apoptosis because of the difficulties to
quantify nuclear fragmentation of DLD-1/   transfectants.
Cells undergoing cell death detached from dish and centrifu-
gation to collect and to stain the cells destroyed large amount
of floating cells. However, as described in Results several
lines of evidence, (a) DNA fragmentation, (b) nuclear frag-
mentation, and (c) activation of caspase, indicate that apop-
tosis is taking place in our experiment and thus support the
correlation between reduced viability and apoptosis.
Linkage to the cytoskeleton but not cadherin-mediated 
change in morphology itself is correlated with 
resistance to sphingosine-induced cell death
The transfection of cells with  -catenin deletion mutants
demonstrated that  -catenin mutants capable of association
with the actin cytoskeleton can induce compaction in three-
dimensional suspension cultures; these mutants also exhibit
an anti–cell death function. These results indicate that the
linkage of the cadherin–catenin complex to the cytoskeleton
is integral in the induction of resistance to cell death. These
mutants induce increased cell–cell contact when the trans-
fectants are cultured on solid substrate, the conditions used
in cell death experiments. Disruption of cell adhesion by
treatment with neutralizing anti–E-cadherin antibodies did
not reduce the resistance to cell death, although the cad-
herin-mediated tight adhesion was lost from  D cells. There-
fore, the increased cell–cell contact does not appear to be re-
sponsible for the increased viability. This phenotype is
induced at the same time as the resistance to cell death but
induced independently by  -catenin expression. Further
studies are needed to clarify the molecular differences be-
tween cells lacking  -catenin and cell treatment with an an-
ticadherin antibody.
Both the middle and COOH-terminal regions may link
the cadherin–catenin complex and the actin cytoskeleton via
different proteins. This redundancy may explain why the ef-
fect of  -catenin on cell death is not specific for either do-
main of the molecule. The middle region of the molecule,
amino acids 203–381, overlaps with the vinculin-binding
region reported to be contained within amino acids 326–
509 (Watabe-Uchida et al., 1998, Imamura et al., 1999). In
addition, amino acids 325–394 have been identified as an
 -actinin–binding site (Nieset et al., 1997). The vincu-
lin- and/or  -actinin–mediated linkage could function in
  C4D cells. The COOH-terminal 210 residues, amino
acids 697–906, interact directly with actin filaments in vitro
(Weiss et al., 1998). In addition, amino acids 697–906 of  -cat-
enin bind to ZO-1 (Imamura et al., 1999). In   NM1D
cells, linkages to the actin cytoskeleton could be established
through direct binding or indirect binding via ZO-1. These
two types of linkage may simultaneously influence death in-
duction and induce close cell–cell contacts.
p27kip1 as a potential mediator of the resistance 
to cell death dependent on  -catenin
p27Kip1 may mediate the signal(s) linking the cadherin–
catenin complex to the apoptotic cascade. This molecule,
originally identified as a cdk inhibitor involved in G1 phase
arrest signaled by TGF  and cell–cell contact (Polyak et al.,
1994), may transduce the signal(s) from the cadherin–cate-
nin complex, resulting in growth suppression (St. Croix et
al., 1998). However, these results could not be applied di-
rectly to our study, since E-cadherin–dependent increases in
p27kip1 were reported to be observed only in three-dimen-
sional suspension cultures not in monolayer cultures. We ex-
amined p27kip1 levels to discover that protein levels were
upregulated in low density cultures of  D cells compared
with those observed in nD cells. The cause of the discrep-
ancy between our results and the previous ones is not clear;
differences in the cell line, cell density, or adhesive disrup-
tion method used may explain these differences. They used
transfection of E-cadherin and its neutralizing antibodies,
whereas we used a deficiency of  -catenin. p27kip1 protein
levels were as high as the levels observed in  D cells in trans-
fectants expressing  -catenin deletion mutants that confer
resistance to cell death.
Transfection-mediated overexpression of p27kip1 de-
creases sensitivity to apoptosis induced by DNA-damaging
drugs (Dimanche-Boitrel et al., 1998; Eymin et al., 1999a,b).
In leukemic cells, p27kip1 overexpression inhibits cyto-
chrome c release from mitochondria and procaspase 3 activa-
tion (Eymin et al., 1999a,b). Release of cytochrome c from
mitochondria is controlled by proteins of the Bcl family;
proapoptotic members of the family, Bax and Bak, accelerate
the opening of mitochondrial permeability transition pore,
whereas antiapoptotic members of the family, such as Bcl-xL,
inhibit (Shimizu et al., 1999). Increases in permeability result
in the relocation of cytochrome c from mitochondria to the
cytosol, aiding the activation of caspases (Li et al., 1997).
These results suggest that p27kip1 may prevent cell death
upstream of mitochondrial events, possibly through Bcl fam-
ily proteins. In this study, analysis of the antiapoptotic Bcl
family and the death mediator caspases demonstrated that
the target(s) facilitating the resistance of  D cells to death
may function upstream of Bcl-xL and/or caspase 3 (or cas-
pase 3–like proteases). This is consistent with the idea that
p27kip1 may link the signal(s) mediated by the cadherin–
catenin complex to death mediator molecules involved in
sphingosine-induced cell death. Finally, increased expression
of p27kip1 in  -catenin–deficient (DLD-1/  ) cells de-
creases the induction of cell death by sphingosine.
Figure 10. Effect of  -catenin expression on cell growth. nD cells 
( ) and  D cells ( ) were seeded at an initial density of 5   10
4 
cells per 35-mm dish. Cell numbers were then determined over a 
period of 5 d, after trypsin/EDTA treatment. The values are the 
means and SD of triplicate counts.582 The Journal of Cell Biology | Volume 154, 2001
The precise mechanism whereby p27kip1 affects the cell
death cascade remains unknown; two possible mechanisms
may mediate this effect dependent or not dependent on cell
cycle progression. In the present study,  -catenin expression
did not suppress cell growth; therefore, a cell cycle–depen-
dent mechanism does not appear likely. In addition, caspase-
mediated cleavage of p27kip1 into a 15-kD NH2-terminal
fragment is required for antiapoptotic activity (Eymin et al.,
1999b). A point mutation of amino acid 108 (D to E), the
putative cleavage site for the caspase, resulted in both resis-
tance to cleavage and the loss of the antiapoptotic function,
preventing both the release of cytochrome c from the mito-
chondria and the activation of caspase 3 (–like proteases).
These findings suggest that p27kip1 possesses an unknown
function, independent of the inhibition of cell cycle progres-
sion. The molecular mechanism(s) underlying the anti–cell
death function remains to be investigated.
Recently, Vasioukhin et al. (2001) showed that  -catenin
deletion induced increased cell proliferation and downregu-
lation of p27kip1 but not elevated apoptotic rate. We do not
know why downregulation of p27kip1 does not lead an ele-
vated apoptosis in their system. One possible explanation
could be the difference in the cell types used in the experi-
ments, that is, normal keratinocytes in their experiments
versus cancer cells in ours.
We demonstrated that  -catenin expression increases re-
sistance to cell death. The deletion mutants of  -catenin, ca-
pable of increasing cell–cell adhesion, can also decrease the
susceptibility to cell death after sphingosine treatment. How-
ever, the anti–cell death function does not require cell–cell
contact itself as indicated by treatment with anti–E-cadherin
antibodies. The  -catenin–induced increases in p27kip1, a
cdk inhibitor, may mediate the anti–cell death function.
Materials and methods
Chemicals and antibodies
D-Sphingosine (sulfate salt), MTT, mouse IgG, and an antivinculin mAb
were purchased from Sigma-Aldrich. An mAb against Bcl-2 was obtained
from Santa Cruz Biotechnology, Inc. Polyclonal antibodies against Bcl-xL
and mAbs against  -catenin, p27kip1, and p21cip1 were purchased from
Transduction Laboratories. An mAb against HA (3F10) was obtained from
Roche Molecular Biochemicals. SHE78-7, an mAb against human E-cad-
herin, was purchased from Takara Shuzo, Co. Both a colorimetric
tetrapeptide substrate, acetyl-Asp-Glu-Val-Asp-p-nitroanilide (Ac-DEVD-
pNA), and a specific inhibitor, acetyl-Asp-Glu-Val-Asp-chloromethylke-
tone (Ac-DEVD-cmk), of caspase 3 (–like proteinase) were obtained from
Calbiochem.
Cells and transfection
DLD-1/   cells, a DLD-1 human colon cancer cell line variant, were pro-
vided by Dr. S.T. Suzuki (Aichi Human Service Center, Kasugai City, Aichi,
Japan). Cells were grown and transfected as described previously (Ozawa,
1998). G418-resistant clones were examined by immunoblotting for the
expression of either  -catenin or the various deletion mutants. Positive
cells were subcloned; a representative for each construct from multiple
transfectant clones was chosen to be used for further studies.
For multicellular suspension cultures, cells were plated in 35-mm
dishes coated previously with polyhydroxyethylmethacrylate (Frisch and
Francis, 1994).
Sphingosine treatment
Cells were seeded at 5   10
4 cells in 35-mm dishes containing 2 ml cul-
ture medium and incubated for 24 h. To induce apoptosis, culture medium
containing either sphingosine or the drug vehicle (DMSO) alone was dis-
pensed into the dishes. The culture dishes were then incubated for 3–24 h
before analysis. Cells were seeded at 2,500 cells per well in 96-well plates
in 100  l of culture medium containing either SHE78-7 or control IgG,
then treated as above for the experiments using an anti–E-cadherin–block-
ing antibody.
Cell viability studies
Cell viability after sphingosine treatment was assessed using the MTT assay
described by Alley et al. (1988). Samples were incubated with MTT for 1 h;
detached cells were then collected by centrifugation and combined with
attached cells. Cell viability was expressed as a percentage of the control
absorbance after subtracting the background absorbance of culture me-
dium without cells.
DNA fragmentation assay
Nucleosomal DNA degradation was assayed as described by Sinha et al.
(1995) with the following modifications. In brief, 2   10
5 cells were
seeded in a 100-mm culture dish and treated with 17.5  M sphingosine
for 18 h. After drug treatment, suspension cells were collected and centri-
fuged. The remaining cells were collected by trypsinization and combined
with the suspension cells. After a wash with ice-cold PBS, cells were lysed
for 10 min at 4 C in 100  l of lysis buffer comprised of 10 mM Tris (pH
7.4), 10 mM EDTA, and 0.5% Triton X-100. The lysate was centrifuged at
27,000 g for 20 min; the resulting supernatant was treated with RNase A
(400  g/ml) for 30 min at 37 C, followed by treatment with proteinase K
(400  g/ml) for 1 h at 37 C. DNA was precipitated with an equal volume
of iso-propanol in the presence of 0.5 M NaCl overnight at  20 C. Total
DNA from each sample was visualized on a 2% agarose gel.
DAPI staining
Cells were grown on coverslips and stained according to the method of the
manufacturer (Rosche Diagnostics GmbH). In brief, the sphingosine-
treated cells were washed once with DAPI-methanol (1  g/ml) and then
incubated in the same solution for 15 min at 37 C. After washing once
with methanol, cells were examined under a fluorescence microscope
with a 330–385-nm excitation filter.
Immunoblotting
Before protein analysis, cells were seeded at 2   10
5 per 100-mm dish in 8
ml culture medium. Culture medium containing sphingosine was dis-
pensed after a 48-h incubation to induce apoptosis. Preliminary experi-
ments demonstrated that cell viability after sphingosine treatment was sim-
ilar to that of cells treated in 35-mm dishes as described above. After drug
treatment, floating cells were centrifuged. After two washes with ice-cold
PBS, we added SDS sample buffer (Laemmli, 1970) to both the cells col-
lected by centrifugation and those attached to the dish. Cells were lysed,
combined, and boiled for 5 min. After SDS-PAGE (12.5% polyacrylamide),
proteins were transferred to nitrocellulose membranes. Proteins were de-
tected as described previously (Ozawa, 1998) with the following antibod-
ies: anti–Bcl-2 (0.2  g/ml), anti–Bcl-xL (0.5  g/ml), anti– -catenin (1.25
 g/ml), anti-HA (0.2  g/ml), anti-p27kip1 (0.5  g/ml), anti-p21cip1 (0.25
 g/ml), and antivinculin (8.4 ng/ml). Antivinculin antibodies were used to
monitor fluctuations in the total protein amount. Blots were quantified with
a scanner (Scan Jet 4c/T; Hewlett Packard) and NIH Image 1.62 f software.
Measurement of caspase 3 (–like) activity
Cells were treated with sphingosine in 100-mm dishes as described above.
After harvesting and washing, cells were resuspended in a hypotonic cell
lysis buffer (20 mM Hepes, pH 7.5, 10 mM KCl, 2mM MgCl2, 2 mM DTT,
2mM PMSF, 10  g/ml leupeptin, and 10  g/ml pepstatin) and lysed by
four cycles of freeze-thaw. Cell lysates were centrifuged for 20 min at
16,000 g; the resulting supernatant was used as the source of enzyme.
Caspase 3 (–like) activity was measured with a colorimetric tetrapeptide,
Ac-DEVD-pNA, in the presence (negative control) or absence (assay) of the
caspase 3 inhibitor Ac-DEVD-cmk as described by Datta et al. (1997). The
activity was calculated to be the difference between the 405-nm absor-
bance of the assay mixture and the negative control.
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